Status:
TERMINATED
Influence of a Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) on Embryonic Aneuploidy Rate and Developmental Potential
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Infertility
Eligibility:
FEMALE
18-35 years
Phase:
PHASE1
Brief Summary
A single centre randomised controlled trial investigating the influence of a novel prematuration system (PMS) using a phosphodiesterase-3 inhibitor for in-vitro maturation of oocytes - pilot study.
Eligibility Criteria
Inclusion
- healthy volunteers, either with PCOS/PCOS-like ovaries, or with normal ovaries, who undergo oocyte donation for research
- AFC at least 10
- AMH: \> 5 μg/L
- Female age \< 36 years
Exclusion
- major uterine or ovarian abnormalities
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT00822874
Start Date
January 1 2009
End Date
October 1 2012
Last Update
December 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Reproductive Medicine
Brussels, Belgium, 1090